103 related articles for article (PubMed ID: 7879180)
21. Effect of platelet-activating factor antagonist on brain injury in rats.
Tokutomi T; Sigemori M; Kikuchi T; Hirohata M
Acta Neurochir Suppl (Wien); 1994; 60():508-10. PubMed ID: 7976632
[TBL] [Abstract][Full Text] [Related]
22. Platelet-activating factor as a vasodepressive mediator of liver ischemia.
Fukuoka T; Nakajima Y; Nakano H
Transplant Proc; 1993 Dec; 25(6):3225-7. PubMed ID: 8266523
[No Abstract] [Full Text] [Related]
23. Effect of platelet activating factor antagonist (TCV-309) on lung injury in dogs with experimentally endotoxin-induced shock.
Okano S; Tagawa M; Urakawa N
J Vet Med Sci; 1995 Aug; 57(4):751-3. PubMed ID: 8519912
[TBL] [Abstract][Full Text] [Related]
24. Combined treatment with endothelin- and PAF-antagonists reduces posttransplant lung ischemia/reperfusion injury.
Stammberger U; Carboni GL; Hillinger S; Schneiter D; Weder W; Schmid RA
J Heart Lung Transplant; 1999 Sep; 18(9):862-8. PubMed ID: 10528748
[TBL] [Abstract][Full Text] [Related]
25. The role of platelet-activating factor in regional myocardial ischemia-reperfusion injury.
Qayumi AK; English JC; Godin DV; Ansley DM; Loucks EB; Lee JU; Kim CW
Ann Thorac Surg; 1998 Jun; 65(6):1690-7. PubMed ID: 9647083
[TBL] [Abstract][Full Text] [Related]
26. Leucocyte and platelet adhesion in different layers of the small bowel during experimental total warm ischaemia and reperfusion.
Beuk RJ; Tangelder GJ; Maassen RL; Quaedackers JS; Heineman E; Oude Egbrink MG
Br J Surg; 2008 Oct; 95(10):1294-304. PubMed ID: 18720462
[TBL] [Abstract][Full Text] [Related]
27. Effect of TCV-309, a novel platelet activating factor antagonist, on hemodynamics in dogs with endotoxin-induced shock.
Okano S; Tagawa M; Urakawa N
J Vet Med Sci; 1995 Apr; 57(2):385-7. PubMed ID: 7492672
[TBL] [Abstract][Full Text] [Related]
28. Inhibitory effect of TCV-309, a novel platelet activating factor (PAF) antagonist, on endotoxin-induced disseminated intravascular coagulation in rats: possible role of PAF in tissue factor generation.
Kawamura M; Terashita Z; Imura Y; Shino A; Nishikawa K
Thromb Res; 1993 May; 70(4):281-93. PubMed ID: 8332959
[TBL] [Abstract][Full Text] [Related]
29. Platelet activating factor interaction with tumor necrosis factor in myocardial ischaemia-reperfusion injury.
Squadrito F; Ioculano M; Altavilla D; Zingarelli B; Canale P; Campo GM; Saitta A; Calapai G; Bussolino F; Caputi AP
J Lipid Mediat; 1993 Aug; 8(1):53-65. PubMed ID: 8257777
[TBL] [Abstract][Full Text] [Related]
30. Warm renal ischemia and reperfusion injury in rats treated with cyclophosphamide and/or granulocyte colony-stimulating factor.
Tomikawa S; Akiyama N; Nagao T; Uchida H
Transplant Proc; 1993 Dec; 25(6):3230-3. PubMed ID: 7505500
[No Abstract] [Full Text] [Related]
31. The platelet activating factor as a pivotal mediator of shock after liver ischemia.
Fukuoka T; Nakajima Y; Nakano H
Surg Today; 1995; 25(4):351-6. PubMed ID: 7633127
[TBL] [Abstract][Full Text] [Related]
32. [Endothelin-1-induced contraction of pregnant rat myometrium: role of platelet-activating factor].
Okawa T; Suzuki H; Endo C; Suzuki Y; Hoshi K; Sato A; Nakanishi H
Nihon Sanka Fujinka Gakkai Zasshi; 1994 Jan; 46(1):43-4. PubMed ID: 8308402
[No Abstract] [Full Text] [Related]
33. Effect of the platelet-activating factor antagonist, TCV-309, and the cyclo-oxygenase inhibitor, ibuprofen, on the haemodynamic changes in canine experimental endotoxic shock.
Yamanaka S; Iwao H; Yukimura T; Kim S; Miura K
Br J Pharmacol; 1993 Dec; 110(4):1501-7. PubMed ID: 8306093
[TBL] [Abstract][Full Text] [Related]
34. An antagonist of platelet-activating factor suppresses endotoxin-induced tumor necrosis factor and mortality in mice pretreated with carrageenan.
Ogata M; Matsumoto T; Koga K; Takenaka I; Kamochi M; Sata T; Yoshida S; Shigematsu A
Infect Immun; 1993 Feb; 61(2):699-704. PubMed ID: 8423096
[TBL] [Abstract][Full Text] [Related]
35. Platelet-activating factor contributes to postischemic vasospasm.
Wang WZ; Guo SZ; Tsai TM; Anderson GL; Miller FN
J Surg Res; 2000 Apr; 89(2):139-46. PubMed ID: 10729242
[TBL] [Abstract][Full Text] [Related]
36. Brief small intestinal ischemia lessens renal ischemia-reperfusion injury in rats.
Song T; Peng YF; Guo SY; Liu YH; Liul LY
Comp Med; 2007 Apr; 57(2):200-5. PubMed ID: 17536621
[TBL] [Abstract][Full Text] [Related]
37. Fibroblast growth factor protects the kidney against ischemia-reperfusion injury.
Cuevas P; Martinez-Coso V; Fu X; Orte L; Reimers D; Giménez-Gallego G; Forssmann WG; Saenz De Tejada I
Eur J Med Res; 1999 Oct; 4(10):403-10. PubMed ID: 10527953
[TBL] [Abstract][Full Text] [Related]
38. The effect of platelet-activating-factor antagonist TCV-309 on arrhythmias and functional recovery during myocardial reperfusion.
Tamura K; Kimura Y; Tamura T; Kitashiro S; Izuoka T; Tsuji H; Iwasaka T; Inada M
Coron Artery Dis; 1994 Mar; 5(3):267-73. PubMed ID: 8199742
[TBL] [Abstract][Full Text] [Related]
39. Effects of a platelet activating factor antagonist on oedema formation following burns.
Ono I; Gunji H; Hasegawa T; Harada H; Kaneko F; Matsuzaki M
Burns; 1993 Jun; 19(3):202-7. PubMed ID: 8507364
[TBL] [Abstract][Full Text] [Related]
40. Intravital microscope studies of the ischemically injured rat kidney during the early phase of reperfusion.
Yin M; Kurvers HA; Tangelder GJ; Booster MH; Daemen JH; Kootstra G
Transplant Proc; 1995 Oct; 27(5):2847-8. PubMed ID: 7482940
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
